Bogle Investment Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-11,600
Closed -$425K 392
2020
Q1
$425K Buy
+11,600
New +$451K 0.04% 209
2016
Q2
Sell
-235,700
Closed -$12.6M 450
2016
Q1
$12.6M Buy
235,700
+188,596
+400% +$9.29M 0.84% 33
2015
Q4
$2.42M Buy
+47,104
New +$2.34M 0.17% 163

Other funds holding PBH

Bogle Investment Management's PBH Position: Q2 2020 in Review

Bogle Investment Management sold out of Prestige Consumer Healthcare (PBH) in Q2 2020, closing a stake of 11,600 shares — an estimated $425K sold.

Bogle Investment Management first reported a position in PBH in Q4 2015 and held it in 3 quarters. The position peaked at $12.6M in Q1 2016. 253 funds tracked by Wall St. Rank hold PBH as of Q2 2020.

  • Bogle Investment Management reported no remaining Prestige Consumer Healthcare position as of Q2 2020 after selling out during the quarter.
  • Bogle Investment Management sold 11,600 Prestige Consumer Healthcare shares in Q2 2020, an estimated $425K.
  • Bogle Investment Management first reported a position in Prestige Consumer Healthcare in Q4 2015 and held it in 3 quarters.
  • Bogle Investment Management's Prestige Consumer Healthcare position peaked at $12.6M in Q1 2016.
  • 253 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2020.

Based on Bogle Investment Management's 13F filing for Q2 2020, filed 13 Aug 2020.